4.8 Article

Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 142, 期 29, 页码 12574-12578

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jacs.0c04722

关键词

-

资金

  1. NSFC [21971153, 21671122]
  2. Chang-Jiang Scholars Program of China
  3. Taishan Scholars Construction Project of Shandong Province
  4. Shandong Provincial Natural Science Foundation [ZR2018MB005]

向作者/读者索取更多资源

(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetonitrile ((S)-CIK) is a key intermediate in the synthesis of (S)-clopidogrel, which is one of the most saleable worldwide antiplatelet and antithrombotic drugs. We show herein a facile method for the direct synthesis of (S)-CIK via Strecker reaction using a homochiral covalent framework catalyst in a heterogeneous way. The asymmetric synthesis involves a photothermal-conversion-triggered, thermally driven reaction which affords (S)-CIK in 98% yield with 94% enantiomeric excess under visible-light irradiation. Furthermore, the above approach is readily extended to a gram-scale level on a fixed-bed continuous-flow model reactor. The potential utility of this strategy is highlighted by the preparation of many more other types of chiral drugs and drug intermediates in a green and facile way.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据